Comparison of discovery rates and prognostic utility of [ 68 Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.
Kilian KlugeHolger EinspielerDavid HaberlClemens SpielvogelDominik AmerellerGerda EggerGero KramerBernhard GrubmüllerShahrokh ShariatMarcus HackerLukas KennerAlexander R HaugPublished in: European journal of nuclear medicine and molecular imaging (2024)
These findings suggest that PSMA PET imaging outperforms ctDNA analysis in detecting prostate cancer across the whole spectrum of disease, while both modalities are independently highly prognostic for survival outcomes.